Presentation imageRetatrutide 20 mg
Triple GIP/GLP-1/glucagon agonist.
20 mg · Research use only
Freedom Diagnostics LLC · Laboratory PDF →
U.S. shipping via USPS Ground Advantage. Availability, shipping and tax confirmed at checkout. Ordering requires a research account.
Research use only. Not for human or veterinary use.
View laboratory COA →Metabolic Signaling category · Search catalog and COAs
Related research materials
- Retatrutide 10 mg · Research use only
- Retatrutide 30 mg · Research use only
Overview
A triple agonist targeting the GIP, GLP-1 and glucagon receptors, studied for multi-pathway metabolic signaling.
Retatrutide is studied for simultaneous activation of the GIP, GLP-1 and glucagon receptors. The added glucagon-receptor component is investigated in research models for its association with energy expenditure alongside the incretin pathways.
Specification
- Catalog code
- SQ-05
- Size
- 20 mg
- Sequence
- 39-residue triple receptor agonist
- Molecular formula
- C₂₂₁H₃₄₃N₄₉O₆₈
- Mass (Da)
- 4731.3
- Supplied format
- Lyophilized powder in a sealed vial
- Storage
- Product-specific storage conditions are not published. Request supplier documentation from the research desk.
- Documentation
- Published COA · SQ-GLP-320
- Class
- Triple receptor agonist
- Studied in
- Metabolic-pathway models
- Use
- Research use only
Documentation
Review the batch-specific laboratory record below.
Lab tested / COA
- Reported purity (HPLC-UV)
- 99.92%
- Lot
- SQ-GLP-320
- Lab sample name
- GLP3-RT 20mg
- Identity confirmed (LC-MS)
- GLP RT
- Received
- 2026-10-26
- Reported
- 2026-10-27
- Tested by
- Freedom Diagnostics LLC
- Net content
- 19.95 mg
- Appearance
- White Lyophilized Powder
- Accession
- 2610260376
Method: HPLC with UV detection coupled with mass spectrometry (LC-MS).
Verify with Freedom Diagnostics: search code Sequ2610260376
Each published COA was issued by independent laboratory Freedom Diagnostics LLC. Purity by HPLC-UV; identity confirmed by LC-MS. See each lot’s COA for the full method and results. Results are specific to the sample(s) tested and are provided for informational purposes only. The materials tested are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic, or clinical applications. Results should be interpreted by qualified professionals within the scope of the intended research. Accuracy and reliability may be influenced by sample integrity, handling, and other experimental variables.
Common questions
Research FAQ: eligibility, shipping, payment and returns
What is Retatrutide studied for?
As a triple GIP/GLP-1/glucagon agonist it is investigated for multi-pathway metabolic signaling, including the energy-expenditure component associated with glucagon-receptor activation.
Why three receptors?
Research examines whether combined incretin-plus-glucagon signaling behaves differently from dual or single agonists in metabolic models.
What does the name Retatrutide refer to?
Retatrutide identifies the triple GIP/GLP-1/glucagon receptor agonist listed here as a research reference material.
How is it supplied?
Each listing identifies the supplied format (lyophilized powder in a sealed vial) and storage conditions. Batch-specific documentation is shown when published. We do not provide reconstitution, dosing or administration guidance.
How is purity verified?
The product page shows the current batch documentation status. When a reviewed certificate is published, open the laboratory PDF for its reported methods and results. Only use analytical methods and identity results explicitly recorded for that batch. For other records, ask the research desk.
Who can order?
These are research-use-only materials sold to qualified researchers and institutions. They are not for human or veterinary use, consumption, or any diagnostic, therapeutic, cosmetic or food application.
For lawful laboratory research only. Not for human or veterinary use. We do not provide reconstitution, dosing or administration guidance.